Skip to main content
EW
NYSE Life Sciences

FDA Approves First Pediatric Surgical Pulmonary Valve, Expanding Edwards' Congenital Portfolio

Tom Rudovsky · Reported by BusinessWire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$85.19
Mkt Cap
$49.104B
52W Low
$72.3
52W High
$96.29
52W Position info
18% above low
Off High info
12% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

EW sits 18% above its 52-week low of $72.3.

Summary

Edwards Lifesciences received FDA approval for AUTUS, the first surgical pulmonary valve designed specifically for pediatric patients with congenital heart disease. The valve is size-adjustable and can be expanded via a minimally invasive transcatheter procedure as the child grows, potentially reducing repeat open-heart surgeries. Clinical data showed 100% freedom from device-related complications at 30 days and no reinterventions through six months. This approval expands Edwards' congenital treatment options and addresses a significant unmet need in pediatric structural heart care. The company has a strong track record in structural heart innovation, and this product could open a new growth avenue in the pediatric segment.

At the time of this announcement, EW was trading at $85.19 on NYSE in the Life Sciences sector, with a market capitalization of approximately $49.1B. The 52-week trading range was $72.30 to $96.29. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

EW - Latest Insights

EW
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $103.00
Real-time Price: $107.00 info
Change: +$4.00 (+4%) info
Market Cap: $61.588B info
EW
Nov 04, 2026, 4:21 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $104.54
Real-time Price: $107.00 info
Change: +$2.46 (+2%) info
Market Cap: $61.588B info
EW
Nov 04, 2026, 4:15 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $99.99
Real-time Price: $107.00 info
Change: +$7.01 (+7%) info
Market Cap: $61.588B info
EW
Nov 02, 2026, 1:25 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $90.76
Real-time Price: $107.00 info
Change: +$16.24 (+18%) info
Market Cap: $61.588B info
EW
Nov 02, 2026, 12:40 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $95.17
Real-time Price: $107.00 info
Change: +$11.83 (+12%) info
Market Cap: $61.588B info